Volume 8, Number 2—February 2002
Research
Epidemiology of Burkholderia cepacia Complex in Patients with Cystic Fibrosis, Canada
Table 4
Number of cystic fibrosis patients infected with Burkholderia cepacia complex genomovar III RAPD strain type, by Canadian province
Province | RAPD strain type |
||||
---|---|---|---|---|---|
01 | 02 | 04 | 06 | Other (BCESM+)a | |
British Columbia | 9 | 11 | 16 | 7 | 10 (5) |
Alberta | 2 | 14 | 16 | 0 | 0 |
Manitoba | 0 | 1 | 1 | 0 | 1 (0) |
Saskatchewan | 0 | 0 | 0 | 0 | 0 |
Ontario | 1 | 223 | 2 | 0 | 7 (5) |
Quebec | 5 | 7 | 1 | 0 | 2 (2) |
Prince Edward Island | 0 | 0 | 0 | 0 | 0 |
New Brunswick | 0 | 0 | 2 | 0 | 1 (0) |
Nova Scotia | 0 | 2 | 12 | 0 | 4 (0) |
Newfoundland |
0 |
13 |
0 |
0 |
0 |
Total | 17 | 271 | 50 | 7 | 25 (12) |
aNumber of patients whose isolates had Burkholderia cepacia epidemic strain marker (BCESM ) in the category “other genomovar III RAPD strain types”. Strain types 01, 02, 04, and 06 all encoded BCESM. RAPD = random amplified polymorphic DNA.
Page created: April 18, 2012
Page updated: April 18, 2012
Page reviewed: April 18, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.